PELI1 and invasive breast carcinoma: Pathological stage progression correlated with increasing PELI1 expression in LIHC, KIRC, CHOL, ESCA, and STAD, but decreasing levels in breast invasive carcinoma (BRCA), kidney chromophobe (KICH), rectal adenocarcinoma (READ), and UCEC (Figure 1C).